Next generation Sequencing Market

Next generation Sequencing Market by Product & Service (Consumables, Platforms, Services, Bioinformatics), Technology (SBS, SMRT), Application (Diagnostic, Drug Discovery, Agriculture), End User (Pharma, Biotech, Academic) - Global Forecasts (2022 - 2026)

Report Code: BT 2697 Apr, 2021, by marketsandmarkets.com

[392 Pages Report] The next generation sequencing market is projected to reach USD 24.2 billion by 2026, growing at a CAGR of 18.7% during the forecast period. Continuous technological innovations in sequencers coupled with the wide-scale adoption of NGS technologies due to its lower price and high efficiency are the some of the factors driving the growth of the NGS market.

Next-generation Sequencing (NGS) Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact on the Next generation Sequencing Market

The COVID-19 pandemic has curtailed the movement of people, goods, and services worldwide, disrupted supply chains, restricted sales operations, marketing efforts, and customer field support, and impeded the shipping and delivery of products to customers. As a result, many companies experienced a decline in the sales of their sequencing consumables, sequencing services, and instrument services in 2020. However, a resurgence in testing numbers is seen as countries gradually ease restrictions on movement. With the COVID-19 pandemic, responding to infectious disease has become a pressing medical issue worldwide. In addition to the development of vaccines and therapeutic drugs, there is a growing call for developing more precise and simple testing technologies and the expansion of testing structures. COVID-19 has also impacted the regulatory environment and practices, as governments and healthcare providers face unprecedented challenges.

Next generation sequencing Market Dynamics

Driver: Declining costs of genome sequencing

The availability of advanced, efficient, and accurate NGS systems at low costs, along with the reduced cost of genome sequencing, has greatly boosted the adoption of the latest NGS technologies globally. Illumina, for example, enabled NGS genome sequencing at ~USD 100 (with a sequencing cost of USD 25–150 per sample) with the launch of its iSeq benchtop sequencer in 2018. This launch came soon after the introduction of its NovaSeq platform in 2017 that enabled genome sequencing at USD 1,000 (as of 2018). In comparison, genome sequencing cost USD 9.4 million in 2007 and USD 95.3 million in 2001. Similarly, Pacific Biosciences aimed to reduce the cost of reading a human genome from USD 12,000 in early 2018 to USD 7,000 in late 2018, and finally to USD 1,000 in early 2019.

Restraint: End-user budget constraints in developing countries

In developing nations is mostly dependent on external funding is mainly responsible for academic R&D. Several academic and research institutes face budget constraints while purchasing advanced and premium-priced equipment & technologies, inspite of continuous efforts by government and private bodies to provide funds for research across the globe. This hampers is the adoption of technologies such as NGS in developing nations.

Opportunity: Application of NGS in precision medicine and molecular diagnostics

In personalized medicine, NGS tools are used to recognize gene expressions, which aids in the development of precision medicine, as per the patient’s characteristics. The discovery of new biomarkers for various diseases, especially cancer, has brought about revolutionary changes in the fields of medical diagnostics. Continuous developments in sequencing technologies and a better understanding of genomics have increased the efficiency of biomarkers in disease detection. Since precise diagnosis and personalized medicine increase survival rates as well as reduce the financial burden on national health insurance programs, governments across the globe are expected to make significant investments in genome sciences, which will ensure a positive future demand for NGS in such applications.

The NGS sequencing services segment is expected to grow at the highest growth rate in 2020.

Some institutes/organizations do not possess the infrastructure to carry out sequencing activities. Additionally, in cases where only a low number of samples need to be sequenced, outsourcing the NGS project is a time- and cost-efficient alternative to acquiring resources with specific skillsets and setting up the infrastructure necessary to carry out NGS efficiently. Therefore, the market is witnessing an increasing trend of outsourcing sequencing to firms at competitive prices. Some of the major players operating in the sequencing services market include BGI (China), Eurofins (Luxembourg), GENEWIZ (US), Macrogen (South Korea), PerkinElmer (US), QIAGEN (Netherlands), and Novogene (China). All of these players are certified service providers approved by sequencing platform companies. The expanding NGS services portfolio of companies, the complexity of NGS procedures, and the adoption of advanced NGS platforms by service providers are the major factors driving the growth of the NGS sequencing services segment.

By technology, nanopore sequencing segment is anticipated to grow at the fastest rate

Nanopore sequencing, considered the fourth generation of sequencing, has emerged as a competitive, portable technology. This emerging technology has applications in basic research, disease/pathogen surveillance, environmental monitoring, food chain surveillance, and self-quantification and microgravity biology. Such factors are expected to drive growth for this segment.

By application, the drug discovery segment accounted for the second largest share of the NGS market in 2020.

The drug discovery segment accounted for second largest share of the NGS market in 2020. Increasing research activities for novel drug discovery by researchers; rising number of agreements, partnerships, and collaborations among NGS market players, academic institutes, and pharmaceutical companies for drug development; and increasing use of NGS during clinical trials for drug discovery and development are driving the growth of this application segment.

By end user, the academic institutes & research centers segment accounted for the largest share of the ngs market in 2020.

The growth of the NGS market for the academic institutes & research centers segment is driven by the increasing number of research studies using NGS products. The favorable funding scenario for genomics research, the growing number of collaborations between NGS market players and academic & research institutes, and the development of cost-effective NGS products and services for researchers are also key factors driving the growth of this market.

North America accounted for the largest share of the next generation sequencing market in 2020.

Favorable initiatives by government and private bodies for the development and adoption of NGS technologies, wide adoption of NGS diagnostics in the region, increasing number of NGS-based research and clinical applications in the region, growing research on cancer and rising awareness of NGS services are some of the factors driving the regional market growth.

Next-generation Sequencing (NGS) Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Key Market Players

Illumina (US), Thermo Fisher Scientific (US), PerkinElmer (US), BGI Group (China), and Agilent Technologies (US), are the prominent players operating in the next generation sequencing market.

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market Size Available for Years

2019–2026

Base Year Considered

2020

Forecast Period

2021–2026

Forecast Units

Value (USD Billion)

Segments Covered

Product, Technology, Application, End User and Region

Geographies Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Companies Covered

The major market players include including Illumina (US), Thermo Fisher Scientific (US), PerkinElmer (US), BGI Group (China), Agilent Technologies (US), Eurofins Scientific (Luxembourg), Pacific Biosciences (US), Oxford Nanopore Technologies (UK), QIAGEN (Netherlands), F. Hoffmann-La Roche AG (Switzerland), GENEWIZ (US), Psomagen, Inc. (South Korea), 10x Genomics (US), Takara Bio (Japan), Zymo Research (US), NuGen Technologies (US), Hamilton Company (US), Beckman Coulter (US), Becton, Dickinson, and Company (US), Lucigen Corporation (US), and Novogene Co., Ltd. (China)

The study categorizes the next generation sequencing market into the following segments and subsegments:

BY PRODUCT

  • NGS Consumables
  • Sequencing Services
    • Exome & Targeted Resequencing & Custom Panels
    • Whole-Genome Sequencing & De Novo Sequencing
    • RNA Sequencing
    • Other Sequencing Services
  • Presequencing Products & Services
    • Library Preparation & Target Enrichment
    • Quality Control
  • NGS Platforms
    • Illumina
      • Novaseq Systems
      • Nextseq Systems
      • Miseq Systems
      • Miniseq Systems
      • iSeq Systems
    • Thermo Fisher Scientific
      • ION PGM Systems
      • ION Proton Systems
      • ION Genestudio Systems
      • Ion Torrent Genexus Systems
    • Oxford Nanopore Technologies
    • Pacific Biosciences
    • Other Platforms
  • Bioinformatics
    • Data Analysis Services
    • NGS Data Analysis Software & Workbenches
    • NGS Storage, Management, & Cloud Computing Solutions
  • Services for NGS Platforms

BY TECHNOLOGY

  • Sequencing by Synthesis
  • ION Semiconductor Sequencing
  • Nanopore Sequencing
  • Single-Molecule Real-Time Sequencing
  • Other Technologies

BY APPLICATION

  • Diagnostics
    • Cancer Diagnostics
    • Infectious Disease Diagnostics
    • Reproductive Health Diagnostics
    • Other Diagnostic Applications
  • Drug Discovery
  • Agricultural & Animal Research
  • Other Applications

BY END USER

  • Academic Institutes & Research Centers
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Clinics
  • Other End Users

BY REGION

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Netherlands
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • The Middle East and Africa

Recent Developments

  • In January 2021, BGI Group received the CE mark approval for the Thalassemia Gene Detection Kit (Combinatorial Probe-Anchor Synthesis Sequencing Method), which can be used for the genetic diagnosis of α, β thalassemia and other hemoglobinopathy or for general population carrier screening.
  • In September 2020, Thermo Fisher Scientific received the US FDA premarket approval for the Oncomine Dx Target Test as an NGS-based companion diagnostic (CDx) test to identify RET fusion-positive, metastatic non-small cell lung cancer (NSCLC) patients receiving GAVRETO (pralsetinib), a targeted therapy developed by Blueprint Medicines.
  • In August 2020, Thermo Fisher Scientific launched hematology-oncology assays for the Ion Torrent Genexus System, which enables simultaneous analysis of DNA mutations and RNA fusion transcripts in myeloid samples in a single day.
  • In July 2020, Thermo Fisher Scientific signed a companion diagnostic (CDx) agreement with Chugai Pharmaceutical Co., Ltd. and applied to the Ministry of Health, Labour, and Welfare (MHLW) to expand the use of the Oncomine Dx Target Test in Japan

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 47)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
    1.3 MARKET SCOPE
        FIGURE 1 NEXT GENERATION SEQUENCING MARKET SEGMENTATION
           1.3.1 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 52)
    2.1 RESEARCH DATA
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                 FIGURE 2 PRIMARY SOURCES
                 FIGURE 3 NGS MARKET: BREAKDOWN OF PRIMARIES
                    2.1.2.1 Key industry insights
    2.2 MARKET SIZE ESTIMATION
        FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS, 2020
        FIGURE 5 AVERAGE MARKET SIZE ESTIMATION, 2020
        FIGURE 6 NGS MARKET: CAGR PROJECTIONS, 2021–2026
        FIGURE 7 NGS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
        FIGURE 8 DATA TRIANGULATION METHODOLOGY
    2.4 RESEARCH ASSUMPTIONS
    2.5 RISK ANALYSIS

3 EXECUTIVE SUMMARY (Page No. - 63)
  FIGURE 9 NGS MARKET, BY PRODUCT & SERVICE, 2021 VS. 2026 (USD MILLION)
  FIGURE 10 NGS MARKET, BY TECHNOLOGY, 2021 VS. 2026 (USD MILLION)
  FIGURE 11 NGS MARKET, BY APPLICATION 2021 VS. 2026 (USD MILLION)
  FIGURE 12 NGS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
  FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE NGS MARKET

4 PREMIUM INSIGHTS (Page No. - 67)
    4.1 NEXT GENERATION SEQUENCING MARKET OVERVIEW
        FIGURE 14 ADVANCEMENTS IN NGS PLATFORMS TO DRIVE MARKET GROWTH
    4.2 NORTH AMERICA: NEXT GENERATION SEQUENCING MARKET SHARE, BY PRODUCT & SERVICE AND COUNTRY (2020)
        FIGURE 15 NGS CONSUMABLES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN NGS MARKET IN 2020
    4.3 NGS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
        FIGURE 16 DIAGNOSTICS SEGMENT WILL CONTINUE TO DOMINATE THE NGS MARKET IN 2026
    4.4 NGS MARKET SHARE, BY END USER, 2020
        FIGURE 17 ACADEMIC INSTITUTES & RESEARCH CENTERS SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2020
    4.5 NGS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
        FIGURE 18 ASIA PACIFIC MARKET TO REGISTER THE HIGHEST GROWTH IN THE NGS MARKET FROM 2021 TO 2026

5 MARKET OVERVIEW (Page No. - 72)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
        FIGURE 19 NEXT GENERATION SEQUENCING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
        TABLE 1 NEXT GENERATION SEQUENCING MARKET: IMPACT ANALYSIS
           5.2.1 DRIVERS
                    5.2.1.1 Advancements in NGS platforms
                               5.2.1.1.1 iSeq 100 System
                               5.2.1.1.2 Ion GeneStudio S5
                    5.2.1.2 Declining costs of genome sequencing
                            FIGURE 20 COST OF HUMAN WHOLE-GENOME SEQUENCING, 2001–2020
                    5.2.1.3 Improving regulatory and reimbursement scenario for NGS-based diagnostic tests
                    5.2.1.4 Growing incidence of cancer and increasing applications of next-generation sequencing in cancer research
                            TABLE 2 GLOBAL CANCER INCIDENCE, 2020 VS. 2040
           5.2.2 RESTRAINTS
                    5.2.2.1 End-user budget constraints in developing countries
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Government & private support for large-scale sequencing
                            TABLE 3 GLOBAL SEQUENCING INITIATIVES
                    5.2.3.2 Application of NGS in precision medicine and molecular diagnostics
                    5.2.3.3 NGS data analysis using big data
                            FIGURE 21 DATA PRODUCTION DURING HUMAN WHOLE-GENOME SEQUENCING, 2001–2019
           5.2.4 CHALLENGES
                    5.2.4.1 Interpretation of complex data from NGS platforms
                    5.2.4.2 Ethical issues
                    5.2.4.3 Introduction of alternative technologies
           5.2.5 INDUSTRY TRENDS
                    5.2.5.1 Development of portable sequencing technologies
                    5.2.5.2 Partnerships & collaborations for technological advancements in NGS
                            TABLE 4 PARTNERSHIPS & COLLABORATIONS, JANUARY 2018–MARCH 2021
    5.3 IMPACT OF THE COVID-19 OUTBREAK ON THE NGS MARKET
    5.4 PORTER’S FIVE FORCES ANALYSIS
        TABLE 5 NGS MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.4.1 THREAT OF NEW ENTRANTS
           5.4.2 THREAT OF SUBSTITUTES
           5.4.3 BARGAINING POWER OF SUPPLIERS
           5.4.4 BARGAINING POWER OF BUYERS
           5.4.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
    5.5 VALUE CHAIN ANALYSIS
        FIGURE 22 VALUE CHAIN ANALYSIS OF THE NEXT GENERATION SEQUENCING MARKET: MANUFACTURING AND ASSEMBLY PHASES ADD MAXIMUM VALUE
        FIGURE 23 VALUE CHAIN: NEXT-GENERATION SEQUENCING ANALYSIS WORKFLOW —MAXIMUM VALUE IS ADDED DURING THE SEQUENCING AND ANALYSIS PHASES
    5.6 TECHNOLOGICAL ANALYSIS
        TABLE 6 SANGER SEQUENCING VS. NGS
    5.7 ECOSYSTEM ANALYSIS
        FIGURE 24 ECOSYSTEM ANALYSIS: NGS MARKET
        TABLE 7 SUPPLY CHAIN ECOSYSTEM
    5.8 PATENT ANALYSIS
        FIGURE 25 PATENT APPLICATIONS FOR NEXT-GENERATION SEQUENCING, JANUARY 2010–DECEMBER 2020
    5.9 PRICING ANALYSIS
        TABLE 8 AVERAGE SELLING PRICE OF NGS SYSTEMS, BY REGION (2020)
    5.10 REGULATORY ANALYSIS
           5.10.1 NORTH AMERICA
                    5.10.1.1 US
                             TABLE 9 US FDA: MEDICAL DEVICE CLASSIFICATION
                             TABLE 10 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                    5.10.1.2 Canada
           5.10.2 EUROPE
           5.10.3 ASIA PACIFIC
                    5.10.3.1 China
                             TABLE 11 CHINA: CLASSIFICATION OF MEDICAL DEVICES
                    5.10.3.2 Japan
                    5.10.3.3 India
           5.10.4 LATIN AMERICA
           5.10.5 MIDDLE EAST

6 NGS MARKET, BY PRODUCT & SERVICE (Page No. - 94)
    6.1 INTRODUCTION
        TABLE 12 NEXT GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
    6.2 NGS CONSUMABLES
           6.2.1 GROWING NUMBER OF SEQUENCING PROCEDURES TO PROPEL THE DEMAND FOR NGS CONSUMABLES
                 TABLE 13 NGS CONSUMABLES MARKET, BY REGION, 2019–2026 (USD MILLION)
                 TABLE 14 NORTH AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 15 EUROPE: NGS CONSUMABLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 16 ASIA PACIFIC: NGS CONSUMABLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 17 LATIN AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    6.3 SEQUENCING SERVICES
        TABLE 18 NGS SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
        TABLE 19 SEQUENCING SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
        TABLE 20 NORTH AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
        TABLE 21 EUROPE: SEQUENCING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
        TABLE 22 ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
        TABLE 23 LATIN AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.3.1 EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS
                    6.3.1.1 Development of technologically advanced NGS products & services to propel the market growth
                            TABLE 24 EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY REGION, 2019–2026 (USD MILLION)
                            TABLE 25 NORTH AMERICA: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                            TABLE 26 EUROPE: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                            TABLE 27 ASIA PACIFIC: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                            TABLE 28 LATIN AMERICA: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.3.2 WHOLE-GENOME SEQUENCING & DE NOVO SEQUENCING
                    6.3.2.1 Reducing whole-genome sequencing costs to propel the growth of this segment
                            TABLE 29 WHOLE-GENOME SEQUENCING & DE NOVO SEQUENCING MARKET, BY REGION, 2019–2026 (USD MILLION)
                            TABLE 30 NORTH AMERICA: WHOLE-GENOME SEQUENCING & DE NOVO SEQUENCING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                            TABLE 31 EUROPE: WHOLE-GENOME SEQUENCING & DE NOVO SEQUENCING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                            TABLE 32 ASIA PACIFIC: WHOLE-GENOME SEQUENCING & DE NOVO SEQUENCING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                            TABLE 33 LATIN AMERICA: WHOLE-GENOME SEQUENCING & DE NOVO SEQUENCING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.3.3 RNA SEQUENCING
                    6.3.3.1 Launch of advanced RNA products & services to drive market growth
                            TABLE 34 RNA SEQUENCING MARKET, BY REGION, 2019–2026 (USD MILLION)
                            TABLE 35 NORTH AMERICA: RNA SEQUENCING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                            TABLE 36 EUROPE: RNA SEQUENCING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                            TABLE 37 ASIA PACIFIC: RNA SEQUENCING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                            TABLE 38 LATIN AMERICA: RNA SEQUENCING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.3.4 OTHER SEQUENCING SERVICES
                 TABLE 39 OTHER SEQUENCING SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
                 TABLE 40 NORTH AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 41 EUROPE: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 42 ASIA PACIFIC: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 43 LATIN AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    6.4 PRESEQUENCING PRODUCTS & SERVICES/SAMPLE PREPARATION
        TABLE 44 PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
        TABLE 45 PRESEQUENCING PRODUCTS & SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
        TABLE 46 NORTH AMERICA: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
        TABLE 47 EUROPE: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
        TABLE 48 ASIA PACIFIC: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
        TABLE 49 LATIN AMERICA: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.4.1 LIBRARY PREPARATION & TARGET ENRICHMENT
                    6.4.1.1 Development of advanced library preparation solutions to drive market growth
                            TABLE 50 LIBRARY PREPARATION & TARGET ENRICHMENT MARKET, BY REGION, 2019–2026 (USD MILLION)
                            TABLE 51 NORTH AMERICA: LIBRARY PREPARATION & TARGET ENRICHMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                            TABLE 52 EUROPE: LIBRARY PREPARATION & TARGET ENRICHMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                            TABLE 53 ASIA PACIFIC: LIBRARY PREPARATION & TARGET ENRICHMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                            TABLE 54 LATIN AMERICA: LIBRARY PREPARATION & TARGET ENRICHMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.4.2 QUALITY CONTROL
                    6.4.2.1 Importance of the quality control step in the NGS workflow is the major factor driving market growth
                            TABLE 55 QUALITY CONTROL MARKET, BY REGION, 2019–2026 (USD MILLION)
                            TABLE 56 NORTH AMERICA: QUALITY CONTROL MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
                            TABLE 57 EUROPE: QUALITY CONTROL MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                            TABLE 58 ASIA PACIFIC: QUALITY CONTROL MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
                            TABLE 59 LATIN AMERICA: QUALITY CONTROL MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    6.5 NGS PLATFORMS
           6.5.1 NGS PLATFORMS MARKET HAS EXPERIENCED A SIGNIFICANT TRANSFORMATION DUE TO THE ENTRY OF NEW PLAYERS
                 TABLE 60 NGS PLATFORMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                 TABLE 61 NGS PLATFORMS MARKET, BY REGION, 2019–2026 (USD MILLION)
                 TABLE 62 NORTH AMERICA: NGS PLATFORMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 63 EUROPE: NGS PLATFORMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 64 ASIA PACIFIC: NGS PLATFORMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 65 LATIN AMERICA: NGS PLATFORMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.5.2 ILLUMINA
                 TABLE 66 ILLUMINA NGS PLATFORMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                 TABLE 67 ILLUMINA NGS PLATFORMS MARKET, BY REGION, 2019–2026 (USD MILLION)
                    6.5.2.1 NovaSeq Systems
                            TABLE 68 NOVASEQ SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)
                    6.5.2.2 NextSeq Systems
                            TABLE 69 NEXTSEQ SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)
                    6.5.2.3 MiSeq Systems
                            TABLE 70 MISEQ SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)
                    6.5.2.4 iSeq 100 Systems
                            TABLE 71 ISEQ 100 SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)
           6.5.3 THERMO FISHER SCIENTIFIC
                 TABLE 72 THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                 TABLE 73 THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET, BY REGION,  2019–2026 (USD MILLION)
           6.5.4 OXFORD NANOPORE TECHNOLOGIES
                 TABLE 74 OXFORD NANOPORE TECHNOLOGIES NGS PLATFORMS MARKET, BY REGION, 2019–2026 (USD MILLION)
           6.5.5 PACIFIC BIOSCIENCES
                 TABLE 75 PACIFIC BIOSCIENCES NGS PLATFORMS MARKET, BY REGION, 2019–2026 (USD MILLION)
           6.5.6 OTHER NGS PLATFORMS
                 TABLE 76 OTHER NGS PLATFORMS MARKET, BY REGION, 2019–2026 (USD MILLION)
    6.6 BIOINFORMATICS
        TABLE 77 BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
        TABLE 78 BIOINFORMATICS MARKET, BY REGION, 2019–2026 (USD MILLION)
        TABLE 79 NORTH AMERICA: BIOINFORMATICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
        TABLE 80 EUROPE: BIOINFORMATICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
        TABLE 81 ASIA PACIFIC: BIOINFORMATICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
        TABLE 82 LATIN AMERICA: BIOINFORMATICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.6.1 NGS DATA ANALYSIS SERVICES
                    6.6.1.1 Rising awareness about NGS data analysis services is the major factor supporting market growth
                            TABLE 83 NGS DATA ANALYSIS SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
                            TABLE 84 NORTH AMERICA: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                            TABLE 85 EUROPE: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                            TABLE 86 ASIA PACIFIC: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                            TABLE 87 LATIN AMERICA: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.6.2 NGS DATA ANALYSIS SOFTWARE & WORKBENCHES
                    6.6.2.1 Development of advanced bioinformatics solutions to drive the growth of this segment
                            TABLE 88 NGS DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY REGION, 2019–2026 (USD MILLION)
                            TABLE 89 NORTH AMERICA: NGS DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                            TABLE 90 EUROPE: NGS DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                            TABLE 91 ASIA PACIFIC: NGS DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                            TABLE 92 LATIN AMERICA: NGS DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.6.3 NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS
                    6.6.3.1 Launch of cloud-based solutions to drive the market
                            TABLE 93 NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY REGION, 2019–2026 (USD MILLION)
                            TABLE 94 NORTH AMERICA: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                            TABLE 95 EUROPE: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                            TABLE 96 ASIA PACIFIC: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                            TABLE 97 LATIN AMERICA: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    6.7 SERVICES FOR NGS PLATFORMS
           6.7.1 INCREASING INSTALLATION OF NGS PLATFORMS TO SUPPORT MARKET GROWTH
                 TABLE 98 SERVICES FOR NGS PLATFORMS MARKET, BY REGION, 2019–2026 (USD MILLION)
                 TABLE 99 NORTH AMERICA: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 100 EUROPE: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 101 ASIA PACIFIC: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 102 LATIN AMERICA: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)

7 NGS MARKET, BY TECHNOLOGY (Page No. - 143)
    7.1 INTRODUCTION
        TABLE 103 NEXT-GENERATION SEQUENCING TECHNOLOGIES, BY COMPANY
        TABLE 104 NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
    7.2 SEQUENCING BY SYNTHESIS
           7.2.1 SBS TECHNOLOGY ENABLES THE HIGHEST PRODUCTION OF BASE PAIRS IN A SHORT PERIOD OF TIME
                 TABLE 105 SEQUENCING BY SYNTHESIS MARKET, BY REGION, 2019–2026 (USD MILLION)
                 TABLE 106 NORTH AMERICA: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 107 EUROPE: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 108 ASIA PACIFIC: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 109 LATIN AMERICA: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    7.3 ION SEMICONDUCTOR SEQUENCING
           7.3.1 SIMPLER WORKFLOW AND COST-EFFECTIVENESS ARE SOME OF THE ADVANTAGES OF ION SEMICONDUCTOR SEQUENCING
                 TABLE 110 ION SEMICONDUCTOR SEQUENCING MARKET, BY REGION, 2019–2026 (USD MILLION)
                 TABLE 111 NORTH AMERICA: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 112 EUROPE: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 113 ASIA PACIFIC: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 114 LATIN AMERICA: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    7.4 NANOPORE SEQUENCING
           7.4.1 NANOPORE SEQUENCING IS THE ONLY SEQUENCING TECHNOLOGY WITH DIRECT RNA SEQUENCING CAPABILITIES
                 TABLE 115 NANOPORE SEQUENCING MARKET, BY REGION, 2019–2026 (USD MILLION)
                 TABLE 116 NORTH AMERICA: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 117 EUROPE: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 118 ASIA PACIFIC: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 119 LATIN AMERICA: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    7.5 SINGLE-MOLECULE REAL-TIME SEQUENCING
           7.5.1 SMRT SEQUENCING PRODUCES RESULTS IN A SHORT TIME AND AT LOWER COSTS
                 TABLE 120 SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY REGION, 2019–2026 (USD MILLION)
                 TABLE 121 NORTH AMERICA: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 122 EUROPE: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 123 ASIA PACIFIC: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 124 LATIN AMERICA: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    7.6 OTHER SEQUENCING TECHNOLOGIES
        TABLE 125 OTHER SEQUENCING TECHNOLOGIES MARKET, BY REGION, 2019–2026 (USD MILLION)
        TABLE 126 NORTH AMERICA: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
        TABLE 127 EUROPE: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
        TABLE 128 ASIA PACIFIC: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
        TABLE 129 LATIN AMERICA: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)

8 NGS MARKET, BY APPLICATION (Page No. - 159)
    8.1 INTRODUCTION
        TABLE 130 NGS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
    8.2 DIAGNOSTICS
        TABLE 131 NGS MARKET FOR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION)
        TABLE 132 NGS MARKET FOR DIAGNOSTICS, BY REGION, 2019–2026 (USD MILLION)
        TABLE 133 NORTH AMERICA: NGS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
        TABLE 134 EUROPE: NGS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
        TABLE 135 ASIA PACIFIC: NGS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
        TABLE 136 LATIN AMERICA: NGS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
           8.2.1 CANCER DIAGNOSTICS
                    8.2.1.1 Growing number of new cancer cases to propel market growth
                            TABLE 137 FUNDING FOR CANCER RESEARCH BY AMERICAN CANCER SOCIETY (AS OF MARCH 2021)
                            TABLE 138 NGS MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2019–2026 (USD MILLION)
                            TABLE 139 NORTH AMERICA: NGS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
                            TABLE 140 EUROPE: NGS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
                            TABLE 141 ASIA PACIFIC: NGS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
                            TABLE 142 LATIN AMERICA: NGS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
           8.2.2 INFECTIOUS DISEASE DIAGNOSTICS
                    8.2.2.1 Increasing demand for NGS products for infectious disease diagnostics to drive market growth
                            TABLE 143 NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2019–2026 (USD MILLION)
                            TABLE 144 NORTH AMERICA: NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
                            TABLE 145 EUROPE: NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
                            TABLE 146 ASIA PACIFIC: NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
                            TABLE 147 LATIN AMERICA: NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
           8.2.3 REPRODUCTIVE HEALTH DIAGNOSTICS
                    8.2.3.1 Increasing awareness about the benefits of NIPT to propel market growth
                            TABLE 148 NGS MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY REGION, 2019–2026 (USD MILLION)
                            TABLE 149 NORTH AMERICA: NGS MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
                            TABLE 150 EUROPE: NGS MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
                            TABLE 151 ASIA PACIFIC: NGS MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
                            TABLE 152 LATIN AMERICA: NGS MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
           8.2.4 OTHER DIAGNOSTIC APPLICATIONS
                 TABLE 153 NGS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
                 TABLE 154 NORTH AMERICA: NGS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 155 EUROPE: NGS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 156 ASIA PACIFIC: NGS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 157 LATIN AMERICA: NGS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
    8.3 DRUG DISCOVERY
           8.3.1 INCREASING USE OF NGS DURING CLINICAL TRIALS FOR DRUG DISCOVERY TO SUPPORT MARKET GROWTH
                 TABLE 158 MARKET FOR DRUG DISCOVERY, BY REGION, 2019–2026 (USD MILLION)
                 TABLE 159 NORTH AMERICA: MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 160 EUROPE: MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 161 ASIA PACIFIC: NGS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 162 LATIN AMERICA: MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2019–2026 (USD MILLION)
    8.4 AGRICULTURAL & ANIMAL RESEARCH
           8.4.1 GROWING FUNDING & SUPPORT FOR ANIMAL & PLANT GENOMICS RESEARCH TO DRIVE MARKET GROWTH
                 TABLE 163 MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY REGION, 2019–2026 (USD MILLION)
                 TABLE 164 NORTH AMERICA: NGS MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 165 EUROPE: MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 166 ASIA PACIFIC: NGS MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 167 LATIN AMERICA: MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY COUNTRY, 2019–2026 (USD MILLION)
    8.5 OTHER APPLICATIONS
        TABLE 168 NGS MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
        TABLE 169 NORTH AMERICA: NGS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
        TABLE 170 EUROPE: NGS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
        TABLE 171 ASIA PACIFIC: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
        TABLE 172 LATIN AMERICA: NGS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)

9 NGS MARKET, BY END USER (Page No. - 186)
    9.1 INTRODUCTION
        TABLE 173 NGS MARKET, BY END USER, 2019–2026 (USD MILLION)
    9.2 ACADEMIC INSTITUTES & RESEARCH CENTERS
           9.2.1 DEVELOPMENT OF COST-EFFECTIVE NGS PRODUCTS & SERVICES FOR RESEARCHERS TO PROPEL MARKET GROWTH
                 TABLE 174 MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY REGION, 2019–2026 (USD MILLION)
                 TABLE 175 NORTH AMERICA: NGS MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 176 EUROPE: MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 177 ASIA PACIFIC: NGS MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 178 LATIN AMERICA: NGS MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY COUNTRY, 2019–2026 (USD MILLION)
    9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
           9.3.1 GROWING AGREEMENTS & COLLABORATIONS BETWEEN NGS MARKET PLAYERS AND PHARMA & BIOTECH COMPANIES TO DRIVE MARKET GROWTH
                 TABLE 179 MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION)
                 TABLE 180 NORTH AMERICA: NGS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 181 EUROPE: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 182 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 183 LATIN AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
    9.4 HOSPITALS & CLINICS
           9.4.1 DEVELOPMENT OF ADVANCED NGS-BASED DIAGNOSTIC SOLUTIONS TO DRIVE THE ADOPTION OF NGS IN HOSPITALS & CLINICS
                 TABLE 184 NGS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2019–2026 (USD MILLION)
                 TABLE 185 NORTH AMERICA: MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 186 EUROPE: MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 187 ASIA PACIFIC: NGS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 188 LATIN AMERICA: MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2019–2026 (USD MILLION)
    9.5 OTHER END USERS
        TABLE 189 NEXT GENERATION SEQUENCING MARKET FOR OTHER END USERS, BY REGION, 2019–2026 (USD MILLION)
        TABLE 190 NORTH AMERICA: NGS MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)
        TABLE 191 EUROPE: MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)
        TABLE 192 ASIA PACIFIC: NGS MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)
        TABLE 193 LATIN AMERICA: NGS MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)

10 NGS MARKET, BY REGION (Page No. - 199)
     10.1 INTRODUCTION
          TABLE 194 NEXT GENERATION SEQUENCING MARKET, BY REGION, 2019–2026 (USD MILLION)
     10.2 NORTH AMERICA
          FIGURE 26 NORTH AMERICA: NEXT GENERATION SEQUENCING MARKET SNAPSHOT
          TABLE 195 NORTH AMERICA: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
          TABLE 196 NORTH AMERICA: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
          TABLE 197 NORTH AMERICA: SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 198 NORTH AMERICA: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 199 NORTH AMERICA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
          TABLE 200 NORTH AMERICA: NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
          TABLE 201 NORTH AMERICA: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
          TABLE 202 NORTH AMERICA: MARKET FOR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 203 NORTH AMERICA: NEXT GENERATION SEQUENCING MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.2.1 US
                        10.2.1.1 Growing R&D activities in the US to drive market growth
                                 TABLE 204 US: NGS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 205 US: SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 206 US: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 207 US: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 208 US: NGS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                 TABLE 209 US: NGS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                 TABLE 210 US: NGS MARKET FOR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 211 US: NGS MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.2.2 CANADA
                        10.2.2.1 Increasing government initiatives in genomics research will boost the adoption of NGS
                                 TABLE 212 CANADA: NGS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 213 CANADA: SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 214 CANADA: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 215 CANADA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 216 CANADA: NGS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                 TABLE 217 CANADA: NGS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                 TABLE 218 CANADA: NGS MARKET FOR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 219 CANADA: NGS MARKET, BY END USER, 2019–2026 (USD MILLION)
     10.3 EUROPE
          TABLE 220 EUROPE: NEXT GENERATION SEQUENCING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
          TABLE 221 EUROPE: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
          TABLE 222 EUROPE: SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 223 EUROPE: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 224 EUROPE: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
          TABLE 225 EUROPE: NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
          TABLE 226 EUROPE: NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
          TABLE 227 EUROPE: NEXT GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 228 EUROPE: NEXT GENERATION SEQUENCING MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.3.1 GERMANY
                        10.3.1.1 Germany dominates the European next generation sequencing market
                                 TABLE 229 GERMANY: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 230 GERMANY: SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 231 GERMANY: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 232 GERMANY: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 233 GERMANY: NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                 TABLE 234 GERMANY: NGS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                 TABLE 235 GERMANY: NGS MARKET FOR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 236 GERMANY: NEXT GENERATION SEQUENCING MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.3.2 UK
                        10.3.2.1 Favorable funding scenario for genomics research in the country to support the adoption of NGS
                                 TABLE 237 UK: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 238 UK: SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 239 UK: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 240 UK: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 241 UK: NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                 TABLE 242 UK: NGS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                 TABLE 243 UK: NGS MARKET FOR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 244 UK: NEXT GENERATION SEQUENCING MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.3.3 FRANCE
                        10.3.3.1 Government initiatives to support genomics research—a major factor driving market growth in France
                                 TABLE 245 FRANCE: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 246 FRANCE: SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 247 FRANCE: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 248 FRANCE: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 249 FRANCE: NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                 TABLE 250 FRANCE: NGS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                 TABLE 251 FRANCE: NGS MARKET FOR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 252 FRANCE: NGS MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.3.4 ITALY
                        10.3.4.1 Favorable funding scenario to drive the next generation sequencing market in Italy
                                 TABLE 253 ITALY: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 254 ITALY: SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 255 ITALY: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 256 ITALY: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 257 ITALY: NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                 TABLE 258 ITALY: NGS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                 TABLE 259 ITALY: NGS MARKET FOR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 260 ITALY: NGS MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.3.5 SPAIN
                        10.3.5.1 Increasing number of conferences focusing on NGS to support market growth in Spain
                                 TABLE 261 SPAIN: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 262 SPAIN: SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 263 SPAIN: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 264 SPAIN: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,  2019–2026 (USD MILLION)
                                 TABLE 265 SPAIN: NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                 TABLE 266 SPAIN: NGS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                 TABLE 267 SPAIN: NGS MARKET FOR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 268 SPAIN: NGS MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.3.6 NETHERLANDS
                        10.3.6.1 Large number of conferences and workshops focusing on NGS technologies to boost the NGS market in the Netherlands
                                 TABLE 269 NETHERLANDS: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 270 NETHERLANDS: SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 271 NETHERLANDS: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 272 NETHERLANDS: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 273 NETHERLANDS: NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                 TABLE 274 NETHERLANDS: NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                 TABLE 275 NETHERLANDS: NEXT GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 276 NETHERLANDS: NEXT GENERATION SEQUENCING MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.3.7 REST OF EUROPE
                    TABLE 277 ROE: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                    TABLE 278 ROE: SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 279 ROE: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 280 ROE: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                    TABLE 281 ROE: NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                    TABLE 282 ROE: NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 283 ROE: NEXT GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 284 ROE: NEXT GENERATION SEQUENCING MARKET, BY END USER, 2019–2026 (USD MILLION)
     10.4 ASIA PACIFIC
          FIGURE 27 ASIA PACIFIC: NEXT GENERATION SEQUENCING MARKET SNAPSHOT
          TABLE 285 APAC: NEXT GENERATION SEQUENCING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
          TABLE 286 APAC: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
          TABLE 287 APAC: SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 288 APAC: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 289 APAC: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
          TABLE 290 APAC: NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
          TABLE 291 APAC: NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
          TABLE 292 APAC: NEXT GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 293 APAC: NEXT GENERATION SEQUENCING MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.4.1 CHINA
                        10.4.1.1 China to register the highest growth in the APAC NGS market
                                 TABLE 294 CHINA: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 295 CHINA: SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 296 CHINA: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 297 CHINA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 298 CHINA: NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                 TABLE 299 CHINA: NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                 TABLE 300 CHINA: NEXT GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 301 CHINA: NEXT GENERATION SEQUENCING MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.4.2 JAPAN
                        10.4.2.1 High incidence of genetic disorders in the country has resulted in the increased adoption of NGS
                                 TABLE 302 JAPAN: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 303 JAPAN: SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 304 JAPAN: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 305 JAPAN: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 306 JAPAN: NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                 TABLE 307 JAPAN: NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                 TABLE 308 JAPAN: NEXT GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 309 JAPAN: NEXT GENERATION SEQUENCING MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.4.3 INDIA
                        10.4.3.1 Growing prevalence of target diseases in India to support market growth
                                 TABLE 310 INDIA: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 311 INDIA: SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 312 INDIA: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 313 INDIA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 314 INDIA: NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                 TABLE 315 INDIA: NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                 TABLE 316 INDIA: NEXT GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 317 INDIA: NEXT GENERATION SEQUENCING MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.4.4 AUSTRALIA
                        10.4.4.1 Increasing use of NGS platforms by academic institutes to propel market growth
                                 TABLE 318 AUSTRALIA: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 319 AUSTRALIA: SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 320 AUSTRALIA: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 321 AUSTRALIA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 322 AUSTRALIA: NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                 TABLE 323 AUSTRALIA: NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                 TABLE 324 AUSTRALIA: NEXT GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 325 AUSTRALIA: NEXT GENERATION SEQUENCING MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.4.5 REST OF ASIA PACIFIC
                    TABLE 326 ROAPAC: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                    TABLE 327 ROAPAC: SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 328 ROAPAC: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 329 ROAPAC: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                    TABLE 330 ROAPAC: NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                    TABLE 331 ROAPAC: NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 332 ROAPAC: NEXT GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 333 ROAPAC: NEXT GENERATION SEQUENCING MARKET, BY END USER, 2019–2026 (USD MILLION)
     10.5 LATIN AMERICA
          TABLE 334 LATIN AMERICA: NEXT GENERATION SEQUENCING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
          TABLE 335 LATIN AMERICA: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
          TABLE 336 LATIN AMERICA: SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 337 LATIN AMERICA: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 338 LATIN AMERICA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
          TABLE 339 LATIN AMERICA: NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
          TABLE 340 LATIN AMERICA: NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
          TABLE 341 LATIN AMERICA: NEXT GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 342 LATIN AMERICA: NEXT GENERATION SEQUENCING MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.5.1 BRAZIL
                        10.5.1.1 High prevalence of HIV in Brazil to drive the demand for NGS
                                 TABLE 343 BRAZIL: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 344 BRAZIL: SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 345 BRAZIL: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 346 BRAZIL: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 347 BRAZIL: NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                 TABLE 348 BRAZIL: NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                 TABLE 349 BRAZIL: NEXT GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 350 BRAZIL: NEXT GENERATION SEQUENCING MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.5.2 MEXICO
                        10.5.2.1 Economic growth in Mexico to support the growth of the NGS market
                                 TABLE 351 MEXICO: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 352 MEXICO: SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 353 MEXICO: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 354 MEXICO: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 355 MEXICO: NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                 TABLE 356 MEXICO: NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                 TABLE 357 MEXICO: NEXT GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 358 MEXICO: NEXT GENERATION SEQUENCING MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.5.3 REST OF LATIN AMERICA
                    TABLE 359 ROLA: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                    TABLE 360 ROLA: SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 361 ROLA: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 362 ROLA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                    TABLE 363 ROLA: NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                    TABLE 364 ROLA: NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 365 ROLA: NEXT GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 366 ROLA: NEXT GENERATION SEQUENCING MARKET, BY END USER, 2019–2026 (USD MILLION)
     10.6 MIDDLE EAST & AFRICA
             10.6.1 LAUNCH OF GENOMIC PROGRAMS TO SUPPORT MARKET GROWTH
                    TABLE 367 MEA: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                    TABLE 368 MEA: SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 369 MEA: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 370 MEA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                    TABLE 371 MEA: NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                    TABLE 372 MEA: NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 373 MEA: NEXT GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 374 MEA: NEXT GENERATION SEQUENCING MARKET, BY END USER, 2019–2026 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 286)
     11.1 OVERVIEW
     11.2 MARKET EVALUATION FRAMEWORK
          TABLE 375 MARKET EVALUATION FRAMEWORK: PRODUCT LAUNCHES—MAJOR GROWTH STRATEGY ADOPTED BY MARKET PLAYERS
     11.3 MARKET SHARE ANALYSIS
          FIGURE 28 NEXT GENERATION SEQUENCING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
     11.4 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
          FIGURE 29 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE NEXT GENERATION SEQUENCING MARKET
     11.5 COMPANY EVALUATION QUADRANT
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 PARTICIPANTS
                    FIGURE 30 NEXT GENERATION SEQUENCING MARKET: COMPANY EVALUATION QUADRANT, 2020
     11.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES
             11.6.1 PROGRESSIVE COMPANIES
             11.6.2 STARTING BLOCKS
             11.6.3 RESPONSIVE COMPANIES
             11.6.4 DYNAMIC COMPANIES
                    FIGURE 31 NEXT GENERATION SEQUENCING MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2020
     11.7 COMPANY PRODUCT FOOTPRINT
          TABLE 376 PRODUCT PORTFOLIO ANALYSIS: NEXT GENERATION SEQUENCING MARKET (2020)
     11.8 COMPANY GEOGRAPHIC FOOTPRINT
          TABLE 377 GEOGRAPHIC REVENUE MIX: NEXT GENERATION SEQUENCING MARKET (2020)
     11.9 COMPETITIVE SCENARIO
             11.9.1 NEXT GENERATION SEQUENCING MARKET: PRODUCT LAUNCHES
             11.9.2 NEXT GENERATION SEQUENCING MARKET: DEALS

12 COMPANY PROFILES (Page No. - 298)
     12.1 KEY PLAYERS
             12.1.1 ILLUMINA, INC.
                    TABLE 378 ILLUMINA: BUSINESS OVERVIEW
                    FIGURE 32 ILLUMINA: COMPANY SNAPSHOT (2020)
             12.1.2 THERMO FISHER SCIENTIFIC, INC.
                    TABLE 379 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
                    FIGURE 33 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020)
             12.1.3 BGI GROUP
                    TABLE 380 BGI GROUP: BUSINESS OVERVIEW
             12.1.4 PERKINELMER
                    TABLE 381 PERKINELMER: BUSINESS OVERVIEW
                    FIGURE 34 PERKINELMER: COMPANY SNAPSHOT (2020)
             12.1.5 QIAGEN N.V.
                    TABLE 382 QIAGEN: BUSINESS OVERVIEW
                    FIGURE 35 QIAGEN: COMPANY SNAPSHOT (2020)
             12.1.6 F. HOFFMANN-LA ROCHE AG
                    TABLE 383 F. HOFFMANN-LA ROCHE AG: BUSINESS OVERVIEW
                    FIGURE 36 F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2020)
             12.1.7 EUROFINS SCIENTIFIC
                    TABLE 384 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
                    FIGURE 37 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2020)
             12.1.8 AGILENT TECHNOLOGIES, INC.
                    TABLE 385 AGILENT TECHNOLOGIES: BUSINESS OVERVIEW
                    FIGURE 38 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2020)
             12.1.9 PACIFIC BIOSCIENCES
                    TABLE 386 PACIFIC BIOSCIENCES: BUSINESS OVERVIEW
                    FIGURE 39 PACIFIC BIOSCIENCES: COMPANY SNAPSHOT (2020)
             12.1.10 OXFORD NANOPORE TECHNOLOGIES
                     TABLE 387 OXFORD NANOPORE TECHNOLOGIES: BUSINESS OVERVIEW
             12.1.11 GENEWIZ (A PART OF BROOKS AUTOMATION)
                     TABLE 388 GENEWIZ: BUSINESS OVERVIEW
                     FIGURE 40 BROOKS AUTOMATION, INC.: COMPANY SNAPSHOT (2020)
             12.1.12 PSOMAGEN, INC. (FORMERLY KNOWN AS MACROGEN)
                     TABLE 389 PSOMAGEN: BUSINESS OVERVIEW
             12.1.13 10X GENOMICS
                     TABLE 390 10X GENOMICS: BUSINESS OVERVIEW
             12.1.14 NUGEN TECHNOLOGIES (A PART OF THE TECAN GROUP)
                     TABLE 391 NUGEN TECHNOLOGIES: BUSINESS OVERVIEW
                     FIGURE 41 TECAN GROUP: COMPANY SNAPSHOT (2020)
             12.1.15 ZYMO RESEARCH
                     TABLE 392 ZYMO RESEARCH: BUSINESS OVERVIEW
             12.1.16 TAKARA BIO
                     TABLE 393 TAKARA BIO: BUSINESS OVERVIEW
                     FIGURE 42 TAKARA BIO: COMPANY SNAPSHOT (2021)
     12.2 OTHER COMPANIES
             12.2.1 HAMILTON COMPANY
             12.2.2 BECKMAN COULTER (A SUBSIDIARY OF DANAHER CORPORATION)
             12.2.3 BECTON, DICKINSON AND COMPANY
             12.2.4 GENOTYPIC TECHNOLOGY
             12.2.5 LUCIGEN CORPORATION

13 APPENDIX (Page No. - 384)
     13.1 DISCUSSION GUIDE
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.3 AVAILABLE CUSTOMIZATIONS
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS

This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global next generation sequencing market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the ngs market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

Secondary Data

The secondary sources referred to for this research study include publications from government sources, such as the Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), National Human Genome Research Institute (NHGRI), International Society for Computational Biology (ISCB), NGS & Bioinformatics Journals and Associations, Institute of Bioinformatics and Applied Biotechnology (IBAB), Personalized Medicine Partnership for Cancer, Genome Canada, European Society of Human Genetics (ESHG), European Molecular Biology Laboratory (EMBL), Asia Pacific Society of Human Genetics (APSHG), Biotechnology and Biological Sciences Research Council (BBSRC), and Eurostat. Secondary sources also include corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global next generation sequencing market, which was validated through primary research.

Primary Data

Extensive primary research was conducted after acquiring basic knowledge about the global ngs market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (personnel from pharmaceutical & biotechnology companies, academic institutes & research centers) and supply side (C-level and D-level executives, product managers, and marketing and sales managers of key manufacturers, distributors, and channel partners, among others from tier 1 and tier 2 companies engaged in offering product in next generation sequencing market across five major regions—North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Primary research was used in this report to:

  • Validate the market segmentation defined through a product portfolio assessment of the leading players in the ngs market
  • Understand key industry trends and issues defining the strategic growth objectives of market players
  • Gather both demand- and supply-side validation of the key factors affecting the market growth (such as market drivers, restraints, and opportunities)
  • Validate assumptions for the market sizing and forecasting model used for this study
  • Understand the market position of leading players in the next generation sequencing market and their market shares/rankings

Next-generation Sequencing (NGS) Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Data Triangulation

After arriving at the overall market size, from the market size estimation process explained above, the next generation sequencing market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the ngs market

Report Objectives

  • To define, describe, and forecast the global next generation sequencing market based on product, application, end user, and region.
  • To provide detailed information on the major factors influencing the market growth (such as drivers, restraints, and opportunities).
  • To strategically analyze micromarkets in terms of individual growth trends, future prospects, and contributions to the overall ngs market.
  • To analyze opportunities in the global market for major stakeholders and provide a detailed competitive landscape for market leaders.
  • To forecast the size of the market segments with respect to five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
  • To profile the key players and comprehensively analyze their market shares and core competencies.
  • To track and analyze competitive developments such as new product launches; acquisitions; expansions; and partnerships, collaborations, and agreements

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographical Analysis

  • Further breakdown of the RoE next generation sequencing market, by country
  • Further breakdown of the RoAPAC next generation sequencing market, by country
  • Further breakdown of the Rest of Latin American and Middle Eastern & African next generation sequencing market, by country

Company Information

  • Detailed analysis and profiling of additional market players (up to 5) inclusive of:
    • Business Overview
    • Financial Information
    • Product Offered
    • Developments (Last three years)
Report Code
BT 2697
Published ON
Apr, 2021
Choose License Type
BUY NOW
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
Practices
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Next generation Sequencing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2022 MarketsandMarkets Research Private Ltd. All rights reserved